Alerian Mlp Index Etn Due 28 January 2044 logo

Alerian Mlp Index Etn Due 28 January 2044(AMJB)

$29.020.74%

Market is closed - opens 7 PM, 29 Jul 2024

Insights

  • Alerian Mlp Index Etn Due 28 January 2044 is currently in a neutral trading position according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Alerian Mlp Index Etn Due 28 January 2044 stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Alerian Mlp Index Etn Due 28 January 2044 stock is in a uptrend ↗️
  • Based on analysis of the Pivot Points, the current market trend for Alerian Mlp Index Etn Due 28 January 2044 stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
45.68
Neutral
Stochastic
1.71, 27.84
Neutral
Ultimate Oscillator
28.42
Buy
Stochastic Relative Strength Index
17.52, 42.56
Neutral
Moving Average Convergence Divergence
0.23, 0.31
Sell

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
29.43
Buy
20
29.24
Buy
50
28.53
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
29.29
Buy
20
29.15
Buy
50
28.74
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
29.52
Neutral
20
29.24
Neutral
50
28.46
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
29.32
Sell
20
29.49
Buy
50
29.2
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
29.13
Sell
20
29.49
Buy
50
29.44
Buy

Pivot

Pivot

Value

Resistance L3
30.01
Resistance L2
29.79
Resistance L1
29.37
Pivot Point
29.15
Support L1
28.73
Support L2
28.51
Support L3
28.09

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.